China R&D Reader

Quintiles Transnational, the Durham company that helps drugmakers test and sell new medicines, gets its business from an industry that is trying to ensure its future by shrinking and consolidating.
Drug development is also undergoing significant changes. But Dennis Gillings, Quintiles’ founder and chief executive, sees opportunity as GlaxoSmithKline cuts costs and jobs, Pfizer buys Wyeth [...]

Quintiles has consolidated its China-based Global Central Laboratories and Clinical Development Services (CDS) businesses into a new, 17,000-square-foot facility in Sun Dong Ann Plaza in Beijing. The new site is larger than the CRO’s original laboratory located at the Peking Union Medical College Hospital (PUMCH). The CDS plans to grow to a staff of more [...]

MDS PharmaServices has expanded its services in China, adding significant capacity to its existing central laboratory in Beijing.
The 25,000 sq. ft. addition to the site has given the firm a five-fold increase in testing capacity, four times the amount of space to produce clinical trial kits, and a wider range of specialised clinical trial testing [...]